The Alzheimer’s Association welcomes the news that Lecanemab (Leqembi) received accelerated approval from the FDA as a treatment for Alzheimer’s disease.
— Read on www.alz.org/news/2023/lecanemab-fda-approved
The Alzheimer’s Association welcomes the news that Lecanemab (Leqembi) received accelerated approval from the FDA as a treatment for Alzheimer’s disease.
— Read on www.alz.org/news/2023/lecanemab-fda-approved